The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
about
Menopausal Hormone Therapy, Age, and Chronic Diseases: Perspectives on Statistical Trends.Cardiomyocyte-specific deletion of the G protein-coupled estrogen receptor (GPER) leads to left ventricular dysfunction and adverse remodeling: A sex-specific gene profiling analysis.Weight gain since age of 20 as risk of metabolic syndrome even in non-overweight individuals.
P2860
The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The timing hypothesis: Do coro ...... or time since menopause onset?
@ast
The timing hypothesis: Do coro ...... or time since menopause onset?
@en
type
label
The timing hypothesis: Do coro ...... or time since menopause onset?
@ast
The timing hypothesis: Do coro ...... or time since menopause onset?
@en
prefLabel
The timing hypothesis: Do coro ...... or time since menopause onset?
@ast
The timing hypothesis: Do coro ...... or time since menopause onset?
@en
P2860
P1433
P1476
The timing hypothesis: Do coro ...... or time since menopause onset?
@en
P2093
JoAnn E Manson
Shari S Bassuk
P2860
P304
P356
10.1016/J.METABOL.2016.01.004
P577
2016-01-12T00:00:00Z